Carl Zeiss Meditec AG

Carl Zeiss Meditec AG navigates challenges and opportunities in 2025, driven by strategic partnerships, innovation, and a focus on emerging markets, despite uncertainties in key markets like China and the USA.

Carl Zeiss Meditec AG reported a 10.9% revenue increase to €1.050.5 million in the first half of 2024/25, driven by strategic acquisitions, but faces challenges in China and the USA.

Carl Zeiss Meditec AG is undergoing a leadership change, with CEO Markus Weber stepping down and Maximilian Foerst, head of ZEISS Greater China, set to take over as CEO.